• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻与早期乳腺癌各亚型预后的关系。

The Impact of Young Age for Prognosis by Subtype in Women with Early Breast Cancer.

机构信息

Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, 350001, China.

Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, 350001, China.

出版信息

Sci Rep. 2017 Sep 14;7(1):11625. doi: 10.1038/s41598-017-10414-x.

DOI:10.1038/s41598-017-10414-x
PMID:28912475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5599495/
Abstract

Young age (≤40 years) use to be considered an independent risk factor for the prognosis of women with early-stage breast cancer. We conducted a retrospective analysis to investigate this claim in a population of young patients who were stratified by molecular subtype. We identified 2,125 women with stage I to III breast cancer from the Fujian Medical University Union Hospital. Multivariable Cox proportional hazards models were used to analyze the relationship between age groups stratified by molecular subtype and 5-year disease-free survival (DFS), 5-year distant metastasis-free survival (DMFS), and 5-year breast cancer-specific survival (BCSS). Median follow-up time was 77 months. Patients ≤40 years of age presented with a significantly worse 5-year DFS and 5-year DMFS. In stratified analyses, young women with luminal A subtype disease were associated with a worse 5-year DFS, 5-year DMFS, and 5-year BCSS. Women with luminal B (Her2-) tumors showed a decrease in 5-year DFS and 5-year DMFS. Our findings support the hypothesis that young age seems to be an independent risk factor for the prognosis for breast cancer patients with the luminal A and luminal B (Her2-) subtypes but not in those with luminal B (Her2+), Her2 over-expression, and triple-negative disease.

摘要

年轻(≤40 岁)被认为是早期乳腺癌女性预后的独立危险因素。我们进行了一项回顾性分析,旨在研究分子亚型分层的年轻患者群体中是否存在这种情况。我们从福建医科大学附属协和医院确定了 2125 名 I 期至 III 期乳腺癌患者。多变量 Cox 比例风险模型用于分析按分子亚型分层的年龄组与 5 年无病生存率(DFS)、5 年远处无复发生存率(DMFS)和 5 年乳腺癌特异性生存率(BCSS)之间的关系。中位随访时间为 77 个月。≤40 岁的患者 5 年 DFS 和 5 年 DMFS 明显较差。分层分析显示,年轻女性的 luminal A 型疾病与较差的 5 年 DFS、5 年 DMFS 和 5 年 BCSS 相关。luminal B(Her2-)肿瘤患者的 5 年 DFS 和 5 年 DMFS 下降。我们的研究结果支持这样的假设,即年轻似乎是 luminal A 和 luminal B(Her2-)亚型乳腺癌患者预后的独立危险因素,但不是 luminal B(Her2+)、Her2 过表达和三阴性疾病患者的预后独立危险因素。

相似文献

1
The Impact of Young Age for Prognosis by Subtype in Women with Early Breast Cancer.年轻与早期乳腺癌各亚型预后的关系。
Sci Rep. 2017 Sep 14;7(1):11625. doi: 10.1038/s41598-017-10414-x.
2
[Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].[不同分子亚型乳腺癌首次发生肝转移患者的临床特征及预后]
Zhonghua Gan Zang Bing Za Zhi. 2016 Jun;24(6):422-8. doi: 10.3760/cma.j.issn.1007-3418.2016.06.006.
3
Long-term outcome in young women with breast cancer: a population-based study.年轻女性乳腺癌患者的长期预后:一项基于人群的研究。
Breast Cancer Res Treat. 2016 Nov;160(1):131-143. doi: 10.1007/s10549-016-3983-9. Epub 2016 Sep 13.
4
Luminal B subtype: a key factor for the worse prognosis of young breast cancer patients in China.管腔B亚型:中国年轻乳腺癌患者预后较差的关键因素。
BMC Cancer. 2015 Mar 29;15:201. doi: 10.1186/s12885-015-1207-z.
5
The impact of different tumour subtypes on management and survival of New Zealand women with Stage I-III breast cancer.不同肿瘤亚型对新西兰 I - III 期乳腺癌女性治疗及生存的影响。
N Z Med J. 2018 May 18;131(1475):51-60.
6
The Clinicopathological Factors Associated with Disease Progression in Luminal A Breast Cancer and Characteristics of Metastasis: A Retrospective Study from A Single Center in China.腔面A型乳腺癌疾病进展的临床病理因素及转移特征:来自中国单中心的回顾性研究
Anticancer Res. 2017 Aug;37(8):4549-4556. doi: 10.21873/anticanres.11852.
7
[Clinicopathological characteristics and prognosis of different molecular types of breast cancer].[不同分子类型乳腺癌的临床病理特征及预后]
Zhonghua Yi Xue Za Zhi. 2016 Jun 14;96(22):1733-7. doi: 10.3760/cma.j.issn.0376-2491.2016.22.004.
8
Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy.新辅助化疗后乳腺癌分子亚型的缓解率和病理完全缓解率。
Breast Cancer Res Treat. 2018 Aug;170(3):559-567. doi: 10.1007/s10549-018-4801-3. Epub 2018 Apr 24.
9
Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy.乳腺癌亚型、年龄及淋巴结状态作为保乳治疗后局部复发的预测因素。
Breast Cancer Res Treat. 2017 Jan;161(1):173-179. doi: 10.1007/s10549-016-4031-5. Epub 2016 Nov 3.
10
Effect of node status on breast cancer survival by subtype: a single-center retrospective cohort study.淋巴结状态对不同亚型乳腺癌生存的影响:一项单中心回顾性队列研究
Transl Cancer Res. 2020 Oct;9(10):5900-5908. doi: 10.21037/tcr-20-1117.

引用本文的文献

1
Landscape of Physical Activity and Quality of Life Research in Breast Cancer Survivors: Topic Modeling Analysis.乳腺癌幸存者的身体活动与生活质量研究概况:主题建模分析
J Clin Med. 2025 Aug 8;14(16):5615. doi: 10.3390/jcm14165615.
2
Impact of ovarian function suppression on prognosis in premenopausal patients with HR+/HER2 + early-stage breast cancer: a multi-center retrospective study.卵巢功能抑制对HR+/HER2+早期绝经前乳腺癌患者预后的影响:一项多中心回顾性研究。
BMC Cancer. 2025 Aug 18;25(1):1331. doi: 10.1186/s12885-025-14774-w.
3
Characteristics and clinical outcomes of early-onset gastrointestinal stromal tumors: a population‑based study.早发性胃肠道间质瘤的特征与临床结局:一项基于人群的研究
Transl Cancer Res. 2025 Apr 30;14(4):2220-2232. doi: 10.21037/tcr-24-1942. Epub 2025 Apr 22.
4
Treatment, toxicity, and mortality after subsequent breast cancer in female survivors of childhood cancer.儿童癌症女性幸存者后续患乳腺癌后的治疗、毒性和死亡率。
Nat Commun. 2025 Mar 31;16(1):3088. doi: 10.1038/s41467-025-58434-w.
5
Development of a breast cancer risk assessment and primary prevention pathway for women aged 30-39 years: Views of UK primary care providers on the role of primary care.为 30-39 岁女性制定乳腺癌风险评估和初级预防路径:英国初级保健提供者对初级保健作用的看法。
PLoS One. 2024 Sep 13;19(9):e0308638. doi: 10.1371/journal.pone.0308638. eCollection 2024.
6
Economic evaluation of trastuzumab in HER2-positive early breast cancer in Indonesia: A cost-effectiveness analysis.印度尼西亚曲妥珠单抗治疗人表皮生长因子受体 2 阳性早期乳腺癌的经济性评价:成本效果分析。
PLoS One. 2024 May 24;19(5):e0304483. doi: 10.1371/journal.pone.0304483. eCollection 2024.
7
KDM7A-DT induces genotoxic stress, tumorigenesis, and progression of p53 missense mutation-associated invasive breast cancer.KDM7A-DT诱导基因毒性应激、肿瘤发生以及与p53错义突变相关的浸润性乳腺癌的进展。
Front Oncol. 2024 May 2;14:1227151. doi: 10.3389/fonc.2024.1227151. eCollection 2024.
8
Breast cancer insights from Northern Israel: a comprehensive analysis of survival rates among Jewish and Arab women.来自以色列北部的乳腺癌见解:犹太和阿拉伯女性生存率的综合分析。
Front Oncol. 2024 Apr 24;14:1337521. doi: 10.3389/fonc.2024.1337521. eCollection 2024.
9
Imaging Patterns in Breast Cancer for Women Under 40 Years: A Descriptive Cohort Study.40岁以下女性乳腺癌的影像学特征:一项描述性队列研究。
J Epidemiol Glob Health. 2024 Mar;14(1):63-71. doi: 10.1007/s44197-023-00169-2. Epub 2024 Jan 11.
10
Feasibility and acceptability of offering breast cancer risk assessment to general population women aged 30-39 years: a mixed-methods study protocol.30-39 岁一般人群女性提供乳腺癌风险评估的可行性和可接受性:一项混合方法研究方案。
BMJ Open. 2024 Jan 10;14(1):e078555. doi: 10.1136/bmjopen-2023-078555.

本文引用的文献

1
Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival.诊断时年龄与乳腺癌生存的亚型依赖性关系。
J Clin Oncol. 2016 Sep 20;34(27):3308-14. doi: 10.1200/JCO.2015.65.8013. Epub 2016 Aug 1.
2
Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials.中心评估的雌激素受体(ER)、孕激素受体(PgR)和Ki-67对激素受体阳性、人表皮生长因子受体2(HER2)阴性的绝经前早期乳腺癌患者选择辅助内分泌治疗的预测价值及临床应用:TEXT和SOFT试验
Breast Cancer Res Treat. 2015 Nov;154(2):275-86. doi: 10.1007/s10549-015-3612-z. Epub 2015 Oct 22.
3
A retrospective comparative study of clinicopathological features between young and elderly women with breast cancer.年轻与老年乳腺癌女性临床病理特征的回顾性比较研究。
Int J Clin Exp Med. 2015 Apr 15;8(4):5869-75. eCollection 2015.
4
Predictors of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast Cancer.乳腺癌患者辅助激素治疗停药的预测因素。
J Clin Oncol. 2015 Jul 10;33(20):2262-9. doi: 10.1200/JCO.2014.59.3673. Epub 2015 Jun 1.
5
Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.定制疗法——改善早期乳腺癌的管理:2015年早期乳腺癌初始治疗圣加仑国际专家共识
Ann Oncol. 2015 Aug;26(8):1533-46. doi: 10.1093/annonc/mdv221. Epub 2015 May 4.
6
Luminal B subtype: a key factor for the worse prognosis of young breast cancer patients in China.管腔B亚型:中国年轻乳腺癌患者预后较差的关键因素。
BMC Cancer. 2015 Mar 29;15:201. doi: 10.1186/s12885-015-1207-z.
7
Adjuvant ovarian suppression in premenopausal breast cancer.绝经前乳腺癌的辅助性卵巢抑制
N Engl J Med. 2015 Jan 29;372(5):436-46. doi: 10.1056/NEJMoa1412379. Epub 2014 Dec 11.
8
Prevalence of BRCA1 mutations and responses to neoadjuvant chemotherapy among BRCA1 carriers and non-carriers with triple-negative breast cancer.BRCA1 突变携带者和非携带者中三阴性乳腺癌的 BRCA1 突变流行率和新辅助化疗反应。
Ann Oncol. 2015 Mar;26(3):523-8. doi: 10.1093/annonc/mdu559. Epub 2014 Dec 5.
9
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
10
Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time?年轻女性乳腺癌:乳腺癌亚型的预后意义是否随时间发生了变化?
Breast Cancer Res Treat. 2014 Oct;147(3):617-29. doi: 10.1007/s10549-014-3125-1. Epub 2014 Sep 11.